FitLife Brands, Inc. Insider Trading

FTLF

⊜ Compare

Last 12 months

Insiders bought 72K on the open market and sold nothing.

Net open-market

+72K

4 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

4 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 19, 2026

Get an email when FTLF's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 19	Shannon K. Pappas Director	Bought	1,000	$10.25	10K	New	Form 4
Apr 10	Matthew Lingenbrink Director	Bought	3,000	$9.76	29K	52%	Form 4
Apr 10	Grant Robert Dawson Director	Bought	3,000	$9.98	30K	1.9%	Form 4
Jan 15	Seth Yakatan Director	Bought	164	$15.36	3K	38%	Form 4
Apr 15, 2025	Todd Ordal Director	Bought	300	$12.07	4K	0.5%	Form 4
Apr 14, 2025	Matthew Lingenbrink Director	Bought	3,000	$12.17	37K	107%	Form 4
Mar 31, 2025	Matthew Lingenbrink Director	Bought	2,800	$12.17	34K	New	Form 4
Jan 15, 2025	Todd Ordal Director	Bought	150	$30.37	5K	0.5%	Form 4

Aug 19
Shannon K. Pappas
Director · bought 1,000 at $10.25
10K
New position
Apr 10
Matthew Lingenbrink
Director · bought 3,000 at $9.76
29K
52% of stake
Apr 10
Grant Robert Dawson
Director · bought 3,000 at $9.98
30K
1.9% of stake
Jan 15
Seth Yakatan
Director · bought 164 at $15.36
3K
38% of stake
Apr 15, 2025
Todd Ordal
Director · bought 300 at $12.07
4K
0.5% of stake
Apr 14, 2025
Matthew Lingenbrink
Director · bought 3,000 at $12.17
37K
107% of stake
Mar 31, 2025
Matthew Lingenbrink
Director · bought 2,800 at $12.17
34K
New position
Jan 15, 2025
Todd Ordal
Director · bought 150 at $30.37
5K
0.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch FTLF, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Medicinal Chemicals & Botanical Products · Pick stocks to compare with FTLF

CompareIntrinsic value

MTEXMannatech, Incorporated

$8.64-0.12%52

NAGENiagen Bioscience Inc.

$2.52+6.78%61

NAIINatural Alternatives International Inc.

$1.10+3.77%3

MRMDMariMed Inc.

$0.06+25.83%35

LEEEFLeef Brands Inc.

$0.17+9.74%30

CWLXFC21 Investments Inc.

No recent price8

CRONCronos Group Inc.

$3.51+3.85%81

CHUCCharlie's Holdings Inc.

$0.10-11.65%10

Held by ETFs

FTLF is in 1 US ETF. The largest of them, with FTLF's weight in each:

IVApplied Finance IVS US SMID ETFIVSS0.01%of the fund

Spot a number that looks wrong? Check it in FTLF's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing FTLF

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.